Stammdaten
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.
Unternehmen & Branche
| Name | Cibus, Inc. |
|---|---|
| Ticker | CBUS |
| CIK | 0001705843 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2870 · Agricultural Chemicals |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 63,9 Mio. USD |
| Beta | 1,93 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 3,639,000 | -127,085,000 | -2.78 | 305,047,000 | 21,829,000 |
| 2025-09-30 | 10-Q | 615,000 | -23,541,000 | -0.44 | 330,226,000 | 50,401,000 |
| 2025-06-30 | 10-Q | 933,000 | -25,372,000 | -0.61 | 346,198,000 | 72,123,000 |
| 2025-03-31 | 10-Q | 1,034,000 | -46,886,000 | -1.34 | 335,045,000 | 70,274,000 |
| 2024-12-31 | 10-K | 4,262,000 | -251,388,000 | -10.83 | 350,069,000 | 92,157,000 |
| 2024-09-30 | 10-Q | 1,667,000 | -179,968,000 | -7.63 | 367,874,000 | 108,140,000 |
| 2024-06-30 | 10-Q | 838,000 | -24,883,000 | -1.14 | 553,380,000 | 270,498,000 |
| 2024-03-31 | 10-Q | 545,000 | -23,435,000 | -1.12 | 533,034,000 | 278,217,000 |
| 2023-12-31 | 10-K | 1,817,000 | -267,627,000 | -25.95 | 544,411,000 | 293,470,000 |
| 2023-09-30 | 10-Q | 475,000 | -26,429,000 | -1.59 | 796,235,000 | 463,390,000 |
| 2023-06-30 | 10-Q | 197,000 | -18,690,000 | -3.05 | 814,268,000 | 484,313,000 |
| 2023-03-31 | 10-Q | 42,000 | -5,394,000 | -5.46 | 20,285,000 | 2,667,000 |
| 2022-12-31 | 10-K | 157,000 | -16,891,000 | -18.36 | 22,421,000 | 7,233,000 |
| 2022-09-30 | 10-Q | 42,000 | -5,950,000 | -6.36 | 26,702,000 | 8,844,000 |
| 2022-06-30 | 10-Q | 41,000 | -2,485,000 | -2.66 | 32,017,000 | 13,759,000 |
| 2022-03-31 | 10-Q | 32,000 | -5,619,000 | -1.34 | 38,345,000 | 14,921,000 |
| 2021-12-31 | 10-K | 25,987,000 | -29,199,000 | -0.78 | 37,194,000 | 14,132,000 |
| 2021-09-30 | 10-Q | 7,762,000 | -7,307,000 | -0.20 | 39,521,000 | 15,825,000 |
| 2021-06-30 | 10-Q | 11,880,000 | -4,807,000 | -0.13 | 47,776,000 | 21,896,000 |
| 2021-03-31 | 10-Q | 4,402,000 | -10,028,000 | 52,428,000 | 25,605,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-06-13 | Sauer Noel | Officer, Sr VP, Research | Open Market Sale | -4 | 1.49 | -5.94 | -100,0% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.